The market for gynecological devices and equipment is greatly impacted by the growing awareness of women's health and preventive care. As more women prioritize routine gynecological exams and screenings, demand for state-of-the-art devices and tools for diagnosis and treatment grows, shaping the market's expansion. The prevalence of gynecological problems, such as endometriosis, uterine fibroids, and pelvic inflammatory diseases, fuels demand for certain devices and tools. By shaping market elements, the market responds to the need for workable, symptomatic solutions. Obtaining natural ingredient supplies, expanding production regions, and implementing risk-management plans are all necessary to reduce possible disruptions. Research into women's health is advancing, which helps create new gynecological equipment. Firms are spending a tonne of money investigating to find better options.
Global initiatives aimed at improving women's health have a significant role in the market for gynecological devices and equipment. Efforts aimed at addressing disparities in women's health, increasing access to gynecological care, and improving regenerative health contribute to progress. The market is mostly influenced by the trend toward minimally invasive gynecological medical procedures. Patients' and providers' increasing preference for less intrusive techniques, together with the adoption of state-of-the-art tools and devices for procedures like laparoscopy and hysteroscopy, is impacting the preferences of the business sector.
Global differences in the medical care system have an impact on the accessibility and uptake of gynecological devices. The market's entry in districts and medical services settings is impacted by differences in clinical offices, ability, and assets. Market aspects are influenced by financial variables, such as the moderateness of medical services and the cost of gynecological devices. The acceptance of devices and equipment in diverse medical care settings is influenced by factors including as reasonableness, insurance inclusion, and payback contracts.
The capacity of gynecologists to use advanced devices and equipment is crucial. Project planning and expertise development initiatives ensure a trained workforce capable of utilizing reproductive technologies and influencing market factors. The development of remote conferencing and telemedicine has an impact on the diagnosis and testing of gynecological devices. Administrations of remote medical services contribute to the advancement of admission to gynecological consideration, particularly for patients in remote regions, molding market inclinations.
Report Attribute/Metric | Details |
---|---|
Growth Rate | 聽聽10.80% (2022-2030聽聽Base Year聽聽2021聽聽Forecast Period聽聽2022-2030聽聽Historical Data聽聽2020聽聽Forecast Units聽聽Value (USD Billion)聽聽Report Coverage聽聽Revenue Forecast, Competitive Landscape, Growth Factors, and Trends聽聽Segments Covered聽聽Type of surgical devices, Type of surgical instruments, Application, and End-user聽聽Geographies Covered聽聽North America, Europe, Asia-Pacific, and Rest of the World (RoW)聽聽Key Vendors聽聽B. Braun Melsungen AG (Germany), Boston Scientific Corporation (U.S.), CooperSurgical Inc. (U.S.), Ethicon, Inc. (U.S.), Hologic, Inc. (U.S.), Karl Storz GmbH & Co. KG (Germany), MedGyn Products (U.S.), Medtronic plc (U.S.), Olympus Corporation (Japan), Richard WOLF GmbH (Germany), Sklar Surgical Instruments (U.S.), Stryker Corporation (U.S.), and others.聽聽Key Market Opportunities聽聽New product launches and R&D Amongst major key Players聽聽Key Market Drivers路聽 Increasing cases of gynecological issues路聽 Improving regulatory framework路聽 Growing research funding路聽 Unmet medical needs路聽 Rising competition among market players路聽 Increasing number of gynecology surgeries路聽 Emerging Asian markets路聽 Increasing government assistance |
Gynecological Devices and Instruments Market Size was valued at USD 7.98 Billion in 2023. The Global Gynecological Devices and Instruments industry is projected to grow from USD 10.56 Billion in 2024 to USD 15.67 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 13.56% during the forecast period (2024 - 2032).
It is noted that the improvement in reimbursement policies is the key factor driving the market of gynecological devices and instruments. According to the recent 2018 hysterectomy reimbursement fact sheet, suggested by the Centers for Medicare and Medicaid Services (CMS), the average Medicare payment for supracervical abdominal hysterectomy is USD 983. Whereas, for vaginal hysterectomy, laparoscopy-assisted supracervical Hysterectomy, and laparoscopy-assisted vaginal hysterectomy, the average Medicare payment is USD 1004, USD 915, and USD 1008, respectively.
Various other factors such as the increasing cases of gynecological issues, improving regulatory framework, growing research funding, unmet medical needs, rising competition among market players, increasing number of gynecology surgeries, emerging Asian markets, and increasing government assistance are continuously contributing to the growth of the global market of gynecological devices and instruments.
Despite these drivers, there are some issues associated with the market of gynecological devices and instruments. The high cost of treatment, lack of skilled or trained physicians, and poor healthcare system in low and middle-income countries may hamper the growth of the market.
Developments in improved imaging instruments, such as 3D endoscopes, and innovations in gynecological gadgets that increase the efficacy of minimally invasive surgical techniques are forecasted to fuel the market. increased awareness of women's health issues, technological improvements, the increased incidence of gynecological problems, and the increasing popularity of minimally invasive surgical techniques all play a role.
Product demand is predicted to increase due to rising interest in surgical treatments such female sterilization, ablation, endoscopy, and laparoscopy, as well as rising utilization of disposable items. Industry expansion is forecasted in part because of the increasing popularity of cutting-edge technologies. The epidemic has hastened the process of digitizing medical equipment and other parts of the healthcare system. AI and ML can improve gynecological device administration for a variety of conditions.
February 2023:Samsung introduced an AI-enabled ob/gyn ultrasound system in February 2023. According to Samsung, the HERA W10 Elite system's maker, the system's 2D and 3D visualization of microcirculatory and slow blood with the Advanced MV-Flow feature and large organic light-emitting diode (OLED) display offer better characterization of diverse ultrasound images. HeartAssistTM, an AI-enhanced function of the HERA W10 Elite, offers automated measurement views to aid in fetal heart diagnosis.
In June 2023:Ceek Women's Health will release the Nella Single-Use Vaginal Speculum, which they believe will transform the delivery of gynecological care forever. With considerable consideration given to patient comfort, the Nella Single-Use Vaginal Speculum was made to be as thin as a tampon. It has built-in sidewall retractors and an LED light to help doctors see the cervical area more clearly when doing gynecological exams and treatments. The universal fit makes it easier to track inventory, and the vaginal walls and cervix may be illuminated without hindrance from fluids with the help of the LED light built into the top bill.
The newly chosen cornerback for the NFL, Kelee Ringo, along with his mother and cancer survivor, Tralee Hale, has collaborated with Hologic Inc., a global leader in women’s wellbeing on a campaign that was held on May 08, 2023, to guide females upon the advantages of annual mammography and other important health screenings.
Stryker (NYSE: SYK), one of the global topmost medical technology companies, gave the statement that it had finalized the acquisition on May 02, 2023, of Cerus Endovascular Ltd., which is privately held, commercial-stage, and engaged in making neuro-interventional equipment utilized in the treatment of intracranial aneurysms.
Boston Imaging, or Samsung Corporation, is a US-based corporation which manufactures and sells mainly the medical imaging technology devices or equipments. It launched Hera W10 Elite AI-enabled women's health ultrasound images that is specfically constructed for the utilization in obstetrics and gynecology procedures to bring diagnostic insights closer to clinicians. Additionally, it ulitizes a novel transducer that is useful for endovaginal visualization of the fetal heart and brain.
September 2022:Guardenia Contained Extraction System will be available for purchase in September 2022 from Olympus, a world leader in the development and distribution of advanced technologies for medical and surgical applications. Advanced Surgical Concepts (ASC) Ltd. of Bray, Ireland, has released Guardenia, the newest addition to their line of confined tissue extraction products for use in gynecological surgeries. The system is sold only in the United States by Olympus America Inc., and it is used to isolate and confine tissue before and/or after surgical removal and/or extracorporeal manual morcellation.
September 2022 bore witness to Olympus Corporation’s announcement about VISERA ELITE III being its latest surgical visualization platform tailored for all surgical specialties, including gynecology.
In July 2022, GE Healthcare announced that Voluson Expert 22 utilizes patented graphic-based beam former innovative technology that enhances the image quality and gives greater flexibility within imaging functions. This is the most latest ultrasound system ever developed by GE Healthcare.
In June 2022, UroViu Corp launched Hystero-V, which was introduced into the market alongside the Always Ready endoscopy platform compatible single-use hysteroscope. The semi-rigid Hystero-V is hydrophilic coated, thus offering gentle insertion and superior visualization during intra-uterine procedures.
Endoluxe Company from California launched the Endoluxe eVS HD wireless endoscopic camera in March 2022, equipped with TowerTech used in gynecological surgeries as well as other ENT/urology/ orthopedic/general surgeries.
The market of gynecological devices and instruments is segmented on the basis of type of surgical devices, type of surgical instruments, application, and end-user.
On the basis of type of surgical devices, the gynecological devices and instruments market is classified as gynecological endoscopy devices, endometrial ablation devices, fluid management systems, and female sterilization/contraceptive devices. The gynecological endoscopy devices are further segmented into hysteroscope, colposcope, resectoscope, laparoscope, and endoscopic imaging systems. Endometrial ablation devices are further segmented into hydrothermal ablation devices, Radiofrequency ablation devices, balloon ablation devices, and others. Female sterilization/contraceptive devices are further segmented into permanent birth control and temporary birth control. The temporary birth control segment includes IUD, intravaginal rings, and subdermal contraceptive implants.
On the basis of type of surgical instruments, the market for gynecological devices and instruments is classified as forceps, scissors, trocars, needle holders, vaginal speculums, dilators, uterine sounds, uterine depressors, uterine curettes, and others. The forceps segment is further classified as Allis forceps, artery forceps, and other forceps. The vaginal speculums segment is further classified as sim’s vaginal speculums, Cusco vaginal speculums, graves’ vaginal speculums, pediatric vaginal speculums, Pederson vaginal speculums, and others.
On the basis of application, the market for gynecological devices and instruments is classified as laparoscopy, hysteroscopy, dilation and curettage, colposcopy, cervical cryosurgery, endometrial ablation, endometrial biopsy, and others.
On the basis of end-user, the market is classified as hospitals and clinics, ambulatory surgery centers, research and academic institutes, and others.
The Americas dominates the gynecological devices market owing to the increasing prevalence of gynecological problems, well-developed technology, high healthcare expenditure, and the presence of leading players. According to the statistics suggested by the Center for Disease Control and Prevention (CDC), cervical cancer is one of the leading causes of deaths of women in the United States. It is reported that in 2014, around 12,578 women in the United States were diagnosed with cervical cancer, and nearly 4,115 women in the United States died from cervical cancer.
Europe holds the second position in the market of gynecological devices and instruments. It is expected that the rising contribution towards research and development and increasing competition among marketers are likely to drive the European gynecological devices and instruments market.
Asia Pacific is the fastest growing gynecological devices and instruments market owing to a huge patient pool, increasing demand for treatment, and rising healthcare expenditure. As per the data suggested by the Australian Institute of Health and Welfare during the year 2015–2016, the total health expenditure was nearly USD 170.4 billion, i.e., 3.6% higher than the expenditure in 2014–2015. The initiatives taken by the government towards gynecological issues are also boosting the market growth. For instance, the Pradhan Mantri Surakshit Matritva Abhiyan (PMSMA) initiated by the Ministry of Health and Family Welfare in 2016, is focusing towards the reduction of maternal and infant mortality rates through safe pregnancies and safe deliveries. This national programme supported around three crore pregnant women across the country by providing special free antenatal care. The main aim of the programme is to detect and prevent high-risk pregnancies.
The Middle East and Africa holds the lowest share of the global market of gynecological devices and instruments due to low development, lack of technical knowledge, and poor medical facilities.
Key Players
Some of the key players in the global gynecological devices and instruments market are
Intended Audience
漏 2024 Market Research Future 庐 (Part of WantStats Reasearch And Media Pvt. Ltd.)